カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の月経困難症用NSAID市場予測2023-2029：イブプロフェン、セレコキシブ、ケトプロフェン、その他

【英語タイトル】NSAIDs for Dysmenorrhea Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23JU5815）・商品コード：MMG23JU5815
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年6月
・ページ数：125
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の月経困難症用NSAID市場規模と予測を収録しています。・世界の月経困難症用NSAID市場：売上、2018年-2023年、2024年-2029年
・世界の月経困難症用NSAID市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の月経困難症用NSAID市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「イブプロフェン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

月経困難症用NSAIDのグローバル主要企業は、IOLCP、 Granules Biocause、 Strides Shasun、 BASF、 SI Group、 Hisoar、 Pfizer Inc、 Teva、 Mylan、 Apotex、 Lupin、 SANOFI-Aventis、 Boehringer-Ingelheim、 BEC Chemicals、 Shandong Xinhua Pharmaceutical、 Hengrui Medicine、 Hubei Biocause Heilen Pharmaceutical、 Zibo Xinhua-PERRIGO Pharmaceutical、 Zhejiang Jiuzhou、 Hubei Xundaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、月経困難症用NSAIDのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の月経困難症用NSAID市場：タイプ別、2018年-2023年、2024年-2029年
世界の月経困難症用NSAID市場：タイプ別市場シェア、2022年
・イブプロフェン、セレコキシブ、ケトプロフェン、その他

世界の月経困難症用NSAID市場：用途別、2018年-2023年、2024年-2029年
世界の月経困難症用NSAID市場：用途別市場シェア、2022年
・病院、診療所、薬局、その他

世界の月経困難症用NSAID市場：地域・国別、2018年-2023年、2024年-2029年
世界の月経困難症用NSAID市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における月経困難症用NSAIDのグローバル売上、2018年-2023年
・主要企業における月経困難症用NSAIDのグローバル売上シェア、2022年
・主要企業における月経困難症用NSAIDのグローバル販売量、2018年-2023年
・主要企業における月経困難症用NSAIDのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
IOLCP、 Granules Biocause、 Strides Shasun、 BASF、 SI Group、 Hisoar、 Pfizer Inc、 Teva、 Mylan、 Apotex、 Lupin、 SANOFI-Aventis、 Boehringer-Ingelheim、 BEC Chemicals、 Shandong Xinhua Pharmaceutical、 Hengrui Medicine、 Hubei Biocause Heilen Pharmaceutical、 Zibo Xinhua-PERRIGO Pharmaceutical、 Zhejiang Jiuzhou、 Hubei Xunda

*************************************************************

・調査・分析レポートの概要
月経困難症用NSAID市場の定義
市場セグメント
世界の月経困難症用NSAID市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の月経困難症用NSAID市場規模
世界の月経困難症用NSAID市場規模：2022年 VS 2029年
世界の月経困難症用NSAID市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの月経困難症用NSAIDの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の月経困難症用NSAID製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：イブプロフェン、セレコキシブ、ケトプロフェン、その他
月経困難症用NSAIDのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、薬局、その他
月経困難症用NSAIDの用途別グローバル売上・予測

・地域別市場分析
地域別月経困難症用NSAID市場規模 2022年と2029年
地域別月経困難症用NSAID売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
IOLCP、 Granules Biocause、 Strides Shasun、 BASF、 SI Group、 Hisoar、 Pfizer Inc、 Teva、 Mylan、 Apotex、 Lupin、 SANOFI-Aventis、 Boehringer-Ingelheim、 BEC Chemicals、 Shandong Xinhua Pharmaceutical、 Hengrui Medicine、 Hubei Biocause Heilen Pharmaceutical、 Zibo Xinhua-PERRIGO Pharmaceutical、 Zhejiang Jiuzhou、 Hubei Xunda
...

Diclofenac, ibuprofen, ketoprofen, meclofenamate, mefenamic acid, and naproxen are the NSAIDs specifically approved by the US Food and Drug Administration (FDA) for treatment of dysmenorrhea.
This report aims to provide a comprehensive presentation of the global market for NSAIDs for Dysmenorrhea, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NSAIDs for Dysmenorrhea. This report contains market size and forecasts of NSAIDs for Dysmenorrhea in global, including the following market information:
Global NSAIDs for Dysmenorrhea Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global NSAIDs for Dysmenorrhea Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five NSAIDs for Dysmenorrhea companies in 2022 (%)
The global NSAIDs for Dysmenorrhea market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Ibuprofen Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of NSAIDs for Dysmenorrhea include IOLCP, Granules Biocause, Strides Shasun, BASF, SI Group, Hisoar, Pfizer Inc, Teva and Mylan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the NSAIDs for Dysmenorrhea manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NSAIDs for Dysmenorrhea Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, by Type, 2022 (%)
Ibuprofen
Celecoxib
Ketoprofen
Others
Global NSAIDs for Dysmenorrhea Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Pharmacy
Other
Global NSAIDs for Dysmenorrhea Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NSAIDs for Dysmenorrhea revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies NSAIDs for Dysmenorrhea revenues share in global market, 2022 (%)
Key companies NSAIDs for Dysmenorrhea sales in global market, 2018-2023 (Estimated), (K Units)
Key companies NSAIDs for Dysmenorrhea sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Hisoar
Pfizer Inc
Teva
Mylan
Apotex
Lupin
SANOFI-Aventis
Boehringer-Ingelheim
BEC Chemicals
Shandong Xinhua Pharmaceutical
Hengrui Medicine
Hubei Biocause Heilen Pharmaceutical
Zibo Xinhua-PERRIGO Pharmaceutical
Zhejiang Jiuzhou
Hubei Xunda
Outline of Major Chapters:
Chapter 1: Introduces the definition of NSAIDs for Dysmenorrhea, market overview.
Chapter 2: Global NSAIDs for Dysmenorrhea market size in revenue and volume.
Chapter 3: Detailed analysis of NSAIDs for Dysmenorrhea manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of NSAIDs for Dysmenorrhea in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global NSAIDs for Dysmenorrhea capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 NSAIDs for Dysmenorrhea Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NSAIDs for Dysmenorrhea Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NSAIDs for Dysmenorrhea Overall Market Size
2.1 Global NSAIDs for Dysmenorrhea Market Size: 2022 VS 2029
2.2 Global NSAIDs for Dysmenorrhea Revenue, Prospects & Forecasts: 2018-2029
2.3 Global NSAIDs for Dysmenorrhea Sales: 2018-2029
3 Company Landscape
3.1 Top NSAIDs for Dysmenorrhea Players in Global Market
3.2 Top Global NSAIDs for Dysmenorrhea Companies Ranked by Revenue
3.3 Global NSAIDs for Dysmenorrhea Revenue by Companies
3.4 Global NSAIDs for Dysmenorrhea Sales by Companies
3.5 Global NSAIDs for Dysmenorrhea Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 NSAIDs for Dysmenorrhea Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers NSAIDs for Dysmenorrhea Product Type
3.8 Tier 1, Tier 2 and Tier 3 NSAIDs for Dysmenorrhea Players in Global Market
3.8.1 List of Global Tier 1 NSAIDs for Dysmenorrhea Companies
3.8.2 List of Global Tier 2 and Tier 3 NSAIDs for Dysmenorrhea Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global NSAIDs for Dysmenorrhea Market Size Markets, 2022 & 2029
4.1.2 Ibuprofen
4.1.3 Celecoxib
4.1.4 Ketoprofen
4.1.5 Others
4.2 By Type – Global NSAIDs for Dysmenorrhea Revenue & Forecasts
4.2.1 By Type – Global NSAIDs for Dysmenorrhea Revenue, 2018-2023
4.2.2 By Type – Global NSAIDs for Dysmenorrhea Revenue, 2024-2029
4.2.3 By Type – Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
4.3 By Type – Global NSAIDs for Dysmenorrhea Sales & Forecasts
4.3.1 By Type – Global NSAIDs for Dysmenorrhea Sales, 2018-2023
4.3.2 By Type – Global NSAIDs for Dysmenorrhea Sales, 2024-2029
4.3.3 By Type – Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
4.4 By Type – Global NSAIDs for Dysmenorrhea Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global NSAIDs for Dysmenorrhea Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacy
5.1.5 Other
5.2 By Application – Global NSAIDs for Dysmenorrhea Revenue & Forecasts
5.2.1 By Application – Global NSAIDs for Dysmenorrhea Revenue, 2018-2023
5.2.2 By Application – Global NSAIDs for Dysmenorrhea Revenue, 2024-2029
5.2.3 By Application – Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
5.3 By Application – Global NSAIDs for Dysmenorrhea Sales & Forecasts
5.3.1 By Application – Global NSAIDs for Dysmenorrhea Sales, 2018-2023
5.3.2 By Application – Global NSAIDs for Dysmenorrhea Sales, 2024-2029
5.3.3 By Application – Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
5.4 By Application – Global NSAIDs for Dysmenorrhea Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global NSAIDs for Dysmenorrhea Market Size, 2022 & 2029
6.2 By Region – Global NSAIDs for Dysmenorrhea Revenue & Forecasts
6.2.1 By Region – Global NSAIDs for Dysmenorrhea Revenue, 2018-2023
6.2.2 By Region – Global NSAIDs for Dysmenorrhea Revenue, 2024-2029
6.2.3 By Region – Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2029
6.3 By Region – Global NSAIDs for Dysmenorrhea Sales & Forecasts
6.3.1 By Region – Global NSAIDs for Dysmenorrhea Sales, 2018-2023
6.3.2 By Region – Global NSAIDs for Dysmenorrhea Sales, 2024-2029
6.3.3 By Region – Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America NSAIDs for Dysmenorrhea Revenue, 2018-2029
6.4.2 By Country – North America NSAIDs for Dysmenorrhea Sales, 2018-2029
6.4.3 US NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.4.4 Canada NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.4.5 Mexico NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe NSAIDs for Dysmenorrhea Revenue, 2018-2029
6.5.2 By Country – Europe NSAIDs for Dysmenorrhea Sales, 2018-2029
6.5.3 Germany NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.4 France NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.5 U.K. NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.6 Italy NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.7 Russia NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.8 Nordic Countries NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.5.9 Benelux NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia NSAIDs for Dysmenorrhea Revenue, 2018-2029
6.6.2 By Region – Asia NSAIDs for Dysmenorrhea Sales, 2018-2029
6.6.3 China NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.6.4 Japan NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.6.5 South Korea NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.6.6 Southeast Asia NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.6.7 India NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America NSAIDs for Dysmenorrhea Revenue, 2018-2029
6.7.2 By Country – South America NSAIDs for Dysmenorrhea Sales, 2018-2029
6.7.3 Brazil NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.7.4 Argentina NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa NSAIDs for Dysmenorrhea Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa NSAIDs for Dysmenorrhea Sales, 2018-2029
6.8.3 Turkey NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.8.4 Israel NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.8.5 Saudi Arabia NSAIDs for Dysmenorrhea Market Size, 2018-2029
6.8.6 UAE NSAIDs for Dysmenorrhea Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 IOLCP
7.1.1 IOLCP Company Summary
7.1.2 IOLCP Business Overview
7.1.3 IOLCP NSAIDs for Dysmenorrhea Major Product Offerings
7.1.4 IOLCP NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.1.5 IOLCP Key News & Latest Developments
7.2 Granules Biocause
7.2.1 Granules Biocause Company Summary
7.2.2 Granules Biocause Business Overview
7.2.3 Granules Biocause NSAIDs for Dysmenorrhea Major Product Offerings
7.2.4 Granules Biocause NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.2.5 Granules Biocause Key News & Latest Developments
7.3 Strides Shasun
7.3.1 Strides Shasun Company Summary
7.3.2 Strides Shasun Business Overview
7.3.3 Strides Shasun NSAIDs for Dysmenorrhea Major Product Offerings
7.3.4 Strides Shasun NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.3.5 Strides Shasun Key News & Latest Developments
7.4 BASF
7.4.1 BASF Company Summary
7.4.2 BASF Business Overview
7.4.3 BASF NSAIDs for Dysmenorrhea Major Product Offerings
7.4.4 BASF NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.4.5 BASF Key News & Latest Developments
7.5 SI Group
7.5.1 SI Group Company Summary
7.5.2 SI Group Business Overview
7.5.3 SI Group NSAIDs for Dysmenorrhea Major Product Offerings
7.5.4 SI Group NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.5.5 SI Group Key News & Latest Developments
7.6 Hisoar
7.6.1 Hisoar Company Summary
7.6.2 Hisoar Business Overview
7.6.3 Hisoar NSAIDs for Dysmenorrhea Major Product Offerings
7.6.4 Hisoar NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.6.5 Hisoar Key News & Latest Developments
7.7 Pfizer Inc
7.7.1 Pfizer Inc Company Summary
7.7.2 Pfizer Inc Business Overview
7.7.3 Pfizer Inc NSAIDs for Dysmenorrhea Major Product Offerings
7.7.4 Pfizer Inc NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Inc Key News & Latest Developments
7.8 Teva
7.8.1 Teva Company Summary
7.8.2 Teva Business Overview
7.8.3 Teva NSAIDs for Dysmenorrhea Major Product Offerings
7.8.4 Teva NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.8.5 Teva Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Company Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan NSAIDs for Dysmenorrhea Major Product Offerings
7.9.4 Mylan NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News & Latest Developments
7.10 Apotex
7.10.1 Apotex Company Summary
7.10.2 Apotex Business Overview
7.10.3 Apotex NSAIDs for Dysmenorrhea Major Product Offerings
7.10.4 Apotex NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.10.5 Apotex Key News & Latest Developments
7.11 Lupin
7.11.1 Lupin Company Summary
7.11.2 Lupin NSAIDs for Dysmenorrhea Business Overview
7.11.3 Lupin NSAIDs for Dysmenorrhea Major Product Offerings
7.11.4 Lupin NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.11.5 Lupin Key News & Latest Developments
7.12 SANOFI-Aventis
7.12.1 SANOFI-Aventis Company Summary
7.12.2 SANOFI-Aventis NSAIDs for Dysmenorrhea Business Overview
7.12.3 SANOFI-Aventis NSAIDs for Dysmenorrhea Major Product Offerings
7.12.4 SANOFI-Aventis NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.12.5 SANOFI-Aventis Key News & Latest Developments
7.13 Boehringer-Ingelheim
7.13.1 Boehringer-Ingelheim Company Summary
7.13.2 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Business Overview
7.13.3 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Major Product Offerings
7.13.4 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.13.5 Boehringer-Ingelheim Key News & Latest Developments
7.14 BEC Chemicals
7.14.1 BEC Chemicals Company Summary
7.14.2 BEC Chemicals Business Overview
7.14.3 BEC Chemicals NSAIDs for Dysmenorrhea Major Product Offerings
7.14.4 BEC Chemicals NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.14.5 BEC Chemicals Key News & Latest Developments
7.15 Shandong Xinhua Pharmaceutical
7.15.1 Shandong Xinhua Pharmaceutical Company Summary
7.15.2 Shandong Xinhua Pharmaceutical Business Overview
7.15.3 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.15.4 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.15.5 Shandong Xinhua Pharmaceutical Key News & Latest Developments
7.16 Hengrui Medicine
7.16.1 Hengrui Medicine Company Summary
7.16.2 Hengrui Medicine Business Overview
7.16.3 Hengrui Medicine NSAIDs for Dysmenorrhea Major Product Offerings
7.16.4 Hengrui Medicine NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.16.5 Hengrui Medicine Key News & Latest Developments
7.17 Hubei Biocause Heilen Pharmaceutical
7.17.1 Hubei Biocause Heilen Pharmaceutical Company Summary
7.17.2 Hubei Biocause Heilen Pharmaceutical Business Overview
7.17.3 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.17.4 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.17.5 Hubei Biocause Heilen Pharmaceutical Key News & Latest Developments
7.18 Zibo Xinhua-PERRIGO Pharmaceutical
7.18.1 Zibo Xinhua-PERRIGO Pharmaceutical Company Summary
7.18.2 Zibo Xinhua-PERRIGO Pharmaceutical Business Overview
7.18.3 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.18.4 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.18.5 Zibo Xinhua-PERRIGO Pharmaceutical Key News & Latest Developments
7.19 Zhejiang Jiuzhou
7.19.1 Zhejiang Jiuzhou Company Summary
7.19.2 Zhejiang Jiuzhou Business Overview
7.19.3 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Major Product Offerings
7.19.4 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.19.5 Zhejiang Jiuzhou Key News & Latest Developments
7.20 Hubei Xunda
7.20.1 Hubei Xunda Company Summary
7.20.2 Hubei Xunda Business Overview
7.20.3 Hubei Xunda NSAIDs for Dysmenorrhea Major Product Offerings
7.20.4 Hubei Xunda NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.20.5 Hubei Xunda Key News & Latest Developments
8 Global NSAIDs for Dysmenorrhea Production Capacity, Analysis
8.1 Global NSAIDs for Dysmenorrhea Production Capacity, 2018-2029
8.2 NSAIDs for Dysmenorrhea Production Capacity of Key Manufacturers in Global Market
8.3 Global NSAIDs for Dysmenorrhea Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NSAIDs for Dysmenorrhea Supply Chain Analysis
10.1 NSAIDs for Dysmenorrhea Industry Value Chain
10.2 NSAIDs for Dysmenorrhea Upstream Market
10.3 NSAIDs for Dysmenorrhea Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 NSAIDs for Dysmenorrhea Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



★調査レポート[世界の月経困難症用NSAID市場予測2023-2029：イブプロフェン、セレコキシブ、ケトプロフェン、その他] (コード：MMG23JU5815)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の月経困難症用NSAID市場予測2023-2029：イブプロフェン、セレコキシブ、ケトプロフェン、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の小児緩和ケア用薬品市場予測2023-2029：パラセタモール、イブプロフェン、モルヒネ、その他
  • 世界の解熱鎮痛抗炎症薬市場予測2023-2029：パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他
  • 世界の消炎鎮痛解熱薬市場予測2023-2029：パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他
  • 世界のペット用NSAID市場予測2023-2029：注射型、経口型、その他
  • 世界の生理痛緩和製品市場予測2023-2029：一次性月経困難症、二次性月経困難症
  • 世界の鎮痛薬市場予測2023-2029：ジェネリック製品オピオイド、ブランド製品オピオイド、NSAID、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆